Anteris Technologies Global (NASDAQ:AVR – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Cantor Fitzgerald in a note issued to investors on Friday,Benzinga reports. They presently have a $15.00 price objective on the stock. Cantor Fitzgerald’s price target suggests a potential upside of 67.97% from the company’s current price.
AVR has been the subject of a number of other reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Barclays upped their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research report on Friday, May 15th. Four research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $16.00.
Check Out Our Latest Research Report on Anteris Technologies Global
Anteris Technologies Global Stock Performance
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.09). The business had revenue of $1.01 million during the quarter, compared to analysts’ expectations of $1.50 million. Anteris Technologies Global had a negative return on equity of 110.36% and a negative net margin of 4,619.27%.During the same quarter in the previous year, the business earned ($0.58) EPS. Equities research analysts forecast that Anteris Technologies Global will post -1.14 EPS for the current fiscal year.
Insider Transactions at Anteris Technologies Global
In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $8.20, for a total value of $4,580,790.60. Following the transaction, the insider directly owned 6,633,314 shares of the company’s stock, valued at $54,393,174.80. The trade was a 7.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders sold 3,000,659 shares of company stock worth $25,174,702. 4.50% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. increased its stake in shares of Anteris Technologies Global by 76.9% in the third quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock worth $29,000 after buying an additional 2,841 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Anteris Technologies Global in the 1st quarter worth $32,000. BNP Paribas Financial Markets grew its holdings in Anteris Technologies Global by 83.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock worth $43,000 after acquiring an additional 4,302 shares during the last quarter. Bank of America Corp DE increased its position in shares of Anteris Technologies Global by 35.7% in the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock valued at $48,000 after acquiring an additional 2,798 shares during the period. Finally, Duncan Williams Asset Management LLC bought a new position in shares of Anteris Technologies Global during the fourth quarter valued at about $54,000.
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- Inside Teledyne’s Bold Bet on the Future of Medical Imaging
- Why Are Analysts Freaking Out About Apple’s All-Glass iPhone?
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
